How Communicating a Diagnosis of Polycystic Ovarian Syndrome (PCOS) Impacts Wellbeing: a Retrospective Community Survey

Overview

Journal BJGP Open

Specialty Public Health

Date 2022 Apr 29

PMID 35487582

Authors

Jane Ogden

Lucy Bridge

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) is associated with wellbeing. Many women report dissatisfaction with the diagnostic process.

Aim: This study assessed the impact of aspects of the diagnostic consultation on subsequent wellbeing.

Design & Setting: A retrospective community survey.

Method: Females with PCOS ( = 147) completed measures of aspects of the diagnostic consultation (consultation satisfaction, language used in terms of framing and focus) and current wellbeing (body esteem, quality of life).

Results: Most diagnoses took place in primary care. The majority showed a medium degree of satisfaction with the consultation. Most diagnoses were framed using a neutral term 'raised' but many used the more judgemental term 'abnormal'. The majority focused on taking oral contraception and weight management. Poorer body esteem (body dissatisfaction and dieting behaviour) and poorer quality of life (self-identity, concerns about fertility, physical health, hirsutism, and overall quality of life) were predicted by lower communication comfort during the diagnostic consultation and greater use of the word 'raised'. Greater use of the word 'irregular' predicted greater concerns about fertility, greater focus on fertility predicted greater concerns about physical health, and greater focus on appearance predicted greater concerns about hirsutism.

Conclusion: How a diagnosis of PCOS is delivered can impact subsequent wellbeing. The diagnostic consultation may take a few minutes, yet how these minutes are managed, what words are used, and how this makes the patient feel may change how the patient makes sense of their condition and influence the impact of the condition on their wellbeing for the longer term.

Citing Articles

Psychological Experiences in Women with Polycystic Ovary Syndrome: A Qualitative Study.

Farajzadegan Z, Kazemi A, Salehi M, ZareMobini F Iran J Nurs Midwifery Res. 2023; 28(4):391-397.

PMID: 37694209 PMC: 10484384. DOI: 10.4103/ijnmr.ijnmr_139_22.

References

Himelein M, Thatcher S . Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv. 2006; 61(11):723-32. DOI: 10.1097/01.ogx.0000243772.33357.84. View

Chou P, Rau K, Yu T, Huang T, Sun J, Wang S . Patient-clinician relationship seems to affect adherence to analgesic use in cancer patients: a cross sectional study in a Taiwanese population. Int J Qual Health Care. 2017; 29(7):935-940. DOI: 10.1093/intqhc/mzx134. View

Teede H, Deeks A, Moran L . Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010; 8:41. PMC: 2909929. DOI: 10.1186/1741-7015-8-41. View

Williams N, Ogden J . The impact of matching the patient's vocabulary: a randomized control trial. Fam Pract. 2004; 21(6):630-5. DOI: 10.1093/fampra/cmh610. View

Tailor A, Ogden J . Avoiding the term 'obesity': an experimental study of the impact of doctors' language on patients' beliefs. Patient Educ Couns. 2009; 76(2):260-4. DOI: 10.1016/j.pec.2008.12.016. View

Lin A, Bergomi E, Dollahite J, Sobal J, Hoeger K, Lujan M . Trust in Physicians and Medical Experience Beliefs Differ Between Women With and Without Polycystic Ovary Syndrome. J Endocr Soc. 2018; 2(9):1001-1009. PMC: 6101505. DOI: 10.1210/js.2018-00181. View

March W, Moore V, Willson K, Phillips D, Norman R, Davies M . The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2009; 25(2):544-51. DOI: 10.1093/humrep/dep399. View

Copp T, Hersch J, Muscat D, McCaffery K, Doust J, Dokras A . The benefits and harms of receiving a polycystic ovary syndrome diagnosis: a qualitative study of women's experiences. Hum Reprod Open. 2019; 2019(4):hoz026. PMC: 6822814. DOI: 10.1093/hropen/hoz026. View

Tayler M, Ogden J . Doctors' use of euphemisms and their impact on patients' beliefs about health: an experimental study of heart failure. Patient Educ Couns. 2005; 57(3):321-6. DOI: 10.1016/j.pec.2004.09.001. View

10.

Lee I, Cooney L, Saini S, Sammel M, Allison K, Dokras A . Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis. Eat Weight Disord. 2018; 24(5):787-797. PMC: 7918293. DOI: 10.1007/s40519-018-0533-y. View

11.

Avery J, Braunack-Mayer A . The information needs of women diagnosed with Polycystic Ovarian Syndrome--implications for treatment and health outcomes. BMC Womens Health. 2007; 7:9. PMC: 1906750. DOI: 10.1186/1472-6874-7-9. View

12.

Kerchner A, Lester W, Stuart S, Dokras A . Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril. 2008; 91(1):207-12. DOI: 10.1016/j.fertnstert.2007.11.022. View

13.

Ogden J, Branson R, Bryett A, Campbell A, Febles A, Ferguson I . What's in a name? An experimental study of patients' views of the impact and function of a diagnosis. Fam Pract. 2003; 20(3):248-53. DOI: 10.1093/fampra/cmg304. View

14.

Azziz R, Sanchez L, Knochenhauer E, Moran C, Lazenby J, Stephens K . Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004; 89(2):453-62. DOI: 10.1210/jc.2003-031122. View

15.

Nasiri-Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour R . The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis. Int J Endocrinol Metab. 2018; 16(2):e12400. PMC: 6035331. DOI: 10.5812/ijem.12400. View

16.

Taylor C, La Greca A, Valenzuela J, Hsin O, Delamater A . Satisfaction with the Health Care Provider and Regimen Adherence in Minority Youth with Type 1 Diabetes. J Clin Psychol Med Settings. 2016; 23(3):257-68. DOI: 10.1007/s10880-016-9460-0. View

17.

Norhayati M, Masseni A, Azlina I . Patient satisfaction with doctor-patient interaction and its association with modifiable cardiovascular risk factors among moderately-high risk patients in primary healthcare. PeerJ. 2017; 5:e2983. PMC: 5322751. DOI: 10.7717/peerj.2983. View

18.

Gibson-Helm M, Lucas I, Boyle J, Teede H . Women's experiences of polycystic ovary syndrome diagnosis. Fam Pract. 2014; 31(5):545-9. DOI: 10.1093/fampra/cmu028. View

19.

Grosset K, Grosset D . Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Mov Disord. 2005; 20(5):616-9. DOI: 10.1002/mds.20393. View

20.

Taghavi S, Bazarganipour F, Montazeri A, Kazemnejad A, Chaman R, Khosravi A . Health-related quality of life in polycystic ovary syndrome patients: A systematic review. Iran J Reprod Med. 2015; 13(8):473-82. PMC: 4637111. View